4th call for proposals launched by the Innovative Medicines Initiative
Monday 18 July 2011
The Innovative Medicines Initiative (IMI) launched its 4th call for proposals which will enable Alzheimer’s disease experts to be involved with the European Medical Information Framework (EMIF) project. The EMIF call has three sub-topics: 1. The creation of the information framework. 2. Obesity research and 3. Alzheimer’s disease research. The goal of the Alzheimer’s disease research topic is to identify predictors of the onset and progression of Alzheimer’s disease in the general population as well as in patients with mild cognitive impairment by using an extreme phenotype approach. This research is supported by the information framework that facilities access to an increased amount of relevant patient-level data.
The duration of the project is 5 years and a total budget of EUR 24 million is being allocated to the EMIF project by European Federation of Pharmaceutical Industries and Associations (EFPIA) and also matched by financial contributions from IMI. Around a quarter of the total budget will be allocated for the Alzheimer’s disease sub topic. The closing data for applications is 18 October 2011.
For further information and an information pack on the 4th call please see the IMI website at: http://www.imi.europa.eu/content/4th-call-2011